Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2

NCT07495865 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2026-04-15

No results posted yet for this study

Summary

Post-market clinical follow-up (PMCF) investigation to evaluate the performance and safety of AnGelHA 2 filler for the correction of moderate to severe wrinkles and folds and facial contour remodeling, in a routine clinical setting.

Conditions

  • Wrinkles

Sponsors & Collaborators

  • Glyance

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-08
Primary Completion
2027-03-12
Completion
2027-03-12

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07495865 on ClinicalTrials.gov